This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
November 18, 2020
SPRUCE BIOSCIENCES REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
November 16, 2020
Vicore Pharma recruits the first patient in the phase II Proof-of-Concept study in idiopathic pulmonary fibrosis
November 13, 2020
InCarda Therapeutics Presents Positive New Data from Phase 2 Study of InRhythm™ in Patients with Paroxysmal Atrial Fibrillation at American Heart Association Scientific Sessions 2020
November 10, 2020
Fusion Pharmaceuticals Announces Third Quarter 2020 Financial Results And Business Update
November 10, 2020
Pulmonx Reports Third Quarter 2020 Financial Results
November 09, 2020
Targovax announces poster at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 06, 2020
Interim report July-September 2020
November 05, 2020
BONESUPPORT HOLDING AB (publ) – Publishes Q3 2020 Interim report
November 05, 2020
Targovax ASA: third quarter 2020 results
November 05, 2020
Aprea Therapeutics Reports Third Quarter 2020 Financial Results and Provides Update on Business Operations